REL and neoplasm: Notably, the reduction in tumor volume was much more pronounced when anti-PD-1 therapy was combined with c-Rel inhibition compared to anti-PD-1 treatment alone, underscoring the necessity of inhibiting c-Rel activity for optimal PD-1 inhibitor efficacy [36].